For ESCC, how many cycles of CCRT is recommended?
- User
For ESCC, how many cycles of CCRT is recommended?
- Assistant
How many “cycles” you give with concurrent chemoradiotherapy (CCRT) for esophageal squamous-cell carcinoma (ESCC) depends on the clinical scenario (neoadjuvant vs. definitive), the drug pair you choose, and the guideline you follow.
Below is a quick-reference summary of the most commonly used evidence-based schedules:Clinical intent Commonly used protocol # chemo cycles actually given during RT Extra “consolidation” cycles after RT? Guideline / trial anchor Neoadjuvant (pre-operative) CROSS: weekly carboplatin (AUC 2) + paclitaxel 50 mg/m² with 41.4 Gy / 23 fx 5 weekly cycles No van Hagen NEJM 2012; NCCN Category 1 Cisplatin 80–100 mg/m² d1 + 5-FU 800–1000 mg/m²/d c.i. d1–4, q3 wk, with 40–45 Gy 2 cycles No JCOG 9907, RTOG 8911, NCCN Definitive (nonsurgical) “Classic” RTOG 85-01: cisplatin 75–100 mg/m² d1 + 5-FU 1000 mg/m²/d c.i. d1–4, q4 wk with 50 Gy 2 cycles during RT 2 additional cycles (total 4) RTOG 85-01; NCCN (optional) Weekly carboplatin (AUC 2) + paclitaxel 50 mg/m² with 50–50.4 Gy 5–6 weekly cycles No RTOG 0436; NCCN FOLFOX (oxaliplatin 85 mg/m² d1, leucovorin, 5-FU bolus + c.i.) q2 wk with 50 Gy 3 cycles during RT No PRODIGE-5/ACCORD 17; NCCN Practical take-home numbers • Neoadjuvant CROSS = 5 weekly cycles.
• Neoadjuvant cisplatin/5-FU = 2 cycles.
• Definitive “classic” CF = 2 cycles during RT ± 2 consolidation (total 4).
• Definitive weekly Carbo/Taxol = 5–6 cycles (one per week of radiation).Why the variation?
- Toxicity: adding consolidation cycles after 50 Gy increases hematologic and GI toxicity without clear survival benefit, so many centers now omit them.
- Logistics: weekly regimens (Carbo/Taxol) fit seamlessly with daily RT and are better tolerated, especially in frail patients.
- Evidence base: CROSS demonstrated a pathologic complete-response rate of ≈30% and survival benefit, so its 5 weekly cycles have become the standard for trimodality therapy.
Bottom line There is no single “magic” cycle number for every ESCC case. The most widely adopted regimens use either: • 5 weekly cycles (Carbo/Taxol) with radiation, or
• 2 cycles of cisplatin/5-FU during radiation (±2 more afterwards).Always individualize based on performance status, organ function, and institutional protocol.
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.